Comparison of two systems for stem cell movilization (G-CSF +/- chemotherapy) in breast cancer patients

被引：0
|
作者：
Isla, D
Herraez, J
Alonso, M
Mayordomo, JI
Cajal, R
Bueso, P
Escudero, P
Moreno, JA
Palomera, L
Tres, A
机构：
[1] HOSP CLIN UNIV,DIV MED ONCOL,ZARAGOZA,SPAIN
[2] HOSP CLIN UNIV,DIV HEMATOL,ZARAGOZA,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：409 / 409
页数：1
相关论文
共 50 条
  • [21] Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Nazha, Aziz
    Cook, Rachel
    Vogl, Dan T.
    Mangan, Patricia A.
    Hummel, Kimberly
    Cunningham, Kathleen
    Luger, Selina
    Porter, David
    Schuster, Stephen J.
    O'Doherty, Una
    Sell, Mary
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 844 - 844
  • [22] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Manko, Joanna
    Walter-Croneck, Adam
    Jawniak, Dariusz
    Grzasko, Norbert
    Gorska-Kosicka, Magdalena
    Cioch, Maria
    Dmoszynska, Anna
    PHARMACOLOGICAL REPORTS, 2014, 66 (02) : 239 - 242
  • [23] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Joanna Manko
    Adam Walter-Croneck
    Dariusz Jawniak
    Norbert Grzasko
    Magdalena Gorska-Kosicka
    Maria Cioch
    Anna Dmoszynska
    Pharmacological Reports, 2014, 66 : 239 - 242
  • [24] Metastatic breast cancer - High doses chemotherapy with G-CSF (filgrastim)
    Temperley, G
    Balbiani, L
    Guzman, M
    Cardoso, C
    Arrieta, S
    Martinez, C
    Comba, AZ
    ANNALS OF ONCOLOGY, 1998, 9 : 30 - 30
  • [25] Characterization of peripheral blood stem cell grafts mobilized by G-CSF and plerixafor in comparison to G-CSF alone
    Gaugler, B.
    Arbez, J.
    Frikeche, J.
    Le Gouill, S.
    Gastinne, T.
    Blin, N.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Rialland, F.
    Mahe, B.
    Dubruille, V.
    Clavert, A.
    Rolland, V.
    Saas, P.
    Moreau, P.
    Derenne, S.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S61 - S62
  • [26] Prospective, randomized study of peripheral blood stem cell (PBSC) mobilization with daniplestim G-CSF versus placebo plus G-CSf in breast cancer patients.
    DiPersio, JF
    Vredenburg, J
    Copelan, EA
    Prosper, F
    Sola, C
    Lill, M
    Bolwell, BJ
    Santos, VR
    Collins, DM
    Baum, CM
    BLOOD, 1998, 92 (10) : 269A - 269A
  • [27] Comparison of G-CSF and GM-CSF in combination with chemotherapy for peripheral blood stem cell (PBSC) mobilization.
    Bojko, P
    Waschek, S
    Seeber, S
    Nowrousian, MR
    BLOOD, 2001, 98 (11) : 177A - 177A
  • [28] Stem cell mobilization with G-CSF following standard ESHAP chemotherapy in patients with lymphoma.
    Berdeja, JG
    Ambinder, RF
    Jones, RJ
    Diehl, LF
    Noga, SS
    Sickler, J
    Carter-Brookins, D
    Piantadosi, S
    Flinn, IW
    BLOOD, 2001, 98 (11) : 179A - 180A
  • [29] High dose chemotherapy (HDC) with G-CSF and peripheral blood stem cell support (PBSC) in advanced breast cancer (ABC)
    Longree, L
    Extra, JM
    Cuvier, C
    Marty, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 381 - 381
  • [30] Successful stem cell mobilization with stem cell factor (SCF) and G-CSF in solid tumor patients failing conventional mobilization with chemotherapy and G-CSF.
    Stachel, DK
    Leipold, A
    Krapf, T
    Ringwald, J
    Strasser, E
    Zingsem, J
    Beck, JD
    Holter, W
    BLOOD, 2002, 100 (11) : 417B - 417B
12345